日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations

大规模泛癌细胞系筛选可确定可行且有效的药物组合

Azadeh C Bashi #, Elizabeth A Coker #, Krishna C Bulusu #, Patricia Jaaks #, Claire Crafter #, Howard Lightfoot, Marta Milo, Katrina McCarten, David F Jenkins, Dieudonne van der Meer, James T Lynch, Syd Barthorpe, Courtney L Andersen, Simon T Barry, Alexandra Beck, Justin Cidado, Jacob A Gordon, Cai

Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer

基于知识图谱的推荐框架可识别 EGFR 突变型非小细胞肺癌的耐药驱动因素

Anna Gogleva, Dimitris Polychronopoulos, Matthias Pfeifer, Vladimir Poroshin, Michaël Ughetto, Matthew J Martin, Hannah Thorpe, Aurelie Bornot, Paul D Smith, Ben Sidders, Jonathan R Dry, Miika Ahdesmäki, Ultan McDermott, Eliseo Papa, Krishna C Bulusu

Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer

新型金刚烷基噻二唑吡唑类药物靶向治疗三阴性乳腺癌中的 EGFR

Anusha Sebastian, Vijay Pandey, Chakrabhavi Dhananjaya Mohan, Yi Ting Chia, Shobith Rangappa, Jessin Mathai, C P Baburajeev, Shardul Paricharak, Lewis H Mervin, Krishna C Bulusu, Julian E Fuchs, Andreas Bender, Shuhei Yamada, Basappa, Peter E Lobie, Kanchugarakoppal S Rangappa

Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo

开发一种新型氮杂螺烷,用于体外和体内肝细胞癌中的 Janus 激酶信号转导和转录激活因子 (STAT) 通路

Chakrabhavi Dhananjaya Mohan, Hanumantharayappa Bharathkumar, Krishna C Bulusu, Vijay Pandey, Shobith Rangappa, Julian E Fuchs, Muthu K Shanmugam, Xiaoyun Dai, Feng Li, Amudha Deivasigamani, Kam M Hui, Alan Prem Kumar, Peter E Lobie, Andreas Bender, Basappa, Gautam Sethi, Kanchugarakoppal S Rangappa